Anebulo Pharmaceuticals I... (ANEB)
NASDAQ: ANEB
· Real-Time Price · USD
2.33
-0.06 (-2.51%)
At close: Sep 05, 2025, 12:52 PM
-2.51% (1D)
| Bid | 2.28 |
| Market Cap | 95.73M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -7.69M |
| EPS (ttm) | -0.25 |
| PE Ratio (ttm) | -9.32 |
| Forward PE | -5.1 |
| Analyst | Hold |
| Ask | 2.41 |
| Volume | 12,433 |
| Avg. Volume (20D) | 405,301 |
| Open | 2.35 |
| Previous Close | 2.39 |
| Day's Range | 2.31 - 2.39 |
| 52-Week Range | 0.80 - 3.42 |
| Beta | -0.89 |
About ANEB
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ANEB
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ANEB stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
+81.97%
Anebulo Pharmaceuticals shares are trading higher ...
Unlock content with
Pro Subscription
3 months ago
+0.5%
Anebulo Pharmaceuticals shares are trading higher after the company reported better-than-expected Q3 EPS results.
